Christopher Hoimes, DO

Showing of 2 results

Next-Generation Immunotherapy Agents Under Study for Early-Stage Bladder Cancer

The new class of drugs known as immune checkpoint inhibitors, which target molecules that serve as checks and balances in the regulation of immune responses, are proving effective against advanced bladder cancer.

1/1/2016 By Christopher Hoimes, DO

UH Seidman Cancer Center Building Entrance.

Genomics for the Next Generation

New approach at UH Seidman Cancer Center simplifies testing, integrates genomics information with other complex tests Innovations in Cancer - Winter 2016 Download PDF Joseph Willis, MD Christopher Hoimes, MD Afshin Dowlati, MD ...

1/1/2016 By Joseph Willis, MD, Christopher Hoimes, DO, Afshin Dowlati, MD, and Shaveta Vinayak, MD

Results are loading...